The biotech sector plays a critical role in several areas of the EU economy. It is research-driven, fast-moving and requires substantial public and private investments.
The Biotech Act will propose a series of measures to create an enabling environment to accelerate the transition of biotech products from laboratory to factory and to the market, while maintaining the highest safety standards for the protection of the population and the environment.
Target audience
The consultation is addressed to citizens, innovators, entrepreneurs, industry, financial institutions, investors/venture capitalists, researchers/research organisations, civil society (including consumer, patient and environmental organisations), other users of biotechnologies (e.g. farmers and foresters), trade unions, national and regional authorities, and any other stakeholders.
Why we are consulting
The consultation strategy aims to ensure that all stakeholders concerned have an opportunity to express their views and share insights on the main challenges faced by the sector across the EU, the measures proposed, and their likely impact.
Stakeholders’ input will feed into the impact assessment for the future European Biotech Act.
Responding to the questionnaire
You can contribute to this consultation by filling in the online questionnaire. If you are unable to use the online questionnaire, please contact us using the email address.
Questionnaires are available in some or all official EU languages. You can submit your responses in any official EU language.
